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Ethanol exposure inhibits protein synthesis and causes cell death in
the developing central nervous system. The double-stranded RNA
(dsRNA)-activated protein kinase (PKR), a serine/threonine protein
kinase, plays an important role in translational regulation and cell sur-
vival. PKR has been well known for its anti-viral response. Upon acti-
vation by viral infection or dsRNA, PKR phosphorylates its substrate,
the-subunitofeukaryotic translation initiationfactor-2 (eIF2) lead-
ing to inhibition of translation initiation. It has recently been shown
that, in the absenceof a virus ordsRNA,PKRcanbe activatedbydirect
interactions with its protein activators, PACT, or its mouse homo-
logue,RAX.Wehavedemonstrated thatexposure toethanol increased
the phosphorylation of PKR and eIF2 in the developing cerebellum.
The effect of ethanol on PKR/eIF2 phosphorylation positively corre-
lated to the expressionofPACT/RAXinculturedneuronal cells.Using
PKR inhibitors and PKR null mouse fibroblasts, we verified that etha-
nol-induced eIF2 phosphorylation was mediated by PKR. Overex-
pression of a wild-type RAX dramatically enhanced sensitivity to eth-
anol-induced PKR/eIF2 phosphorylation, as well as translational
inhibition and cell death. In contrast, overexpression of a mutant
(S18A) RAX inhibited ethanol-mediated PKR/eIF2 activation. Etha-
nol promoted PKR and RAX association in cells expressing wild-type
RAXbut not in cells expressing S18ARAX. S18ARAX functioned as a
dominant negative protein and blocked ethanol-induced inhibition of
protein synthesis and cell death. Our results suggest that the interac-
tions between PKR and PACT/RAXmodulate the effect of ethanol on
protein synthesis and cell survival in the central nervous system.
Fetal alcohol syndrome is the most common non-hereditary cause of
mental retardation (1). Prenatal exposure to alcohol disrupts many
events of neuronal development, including neurogenesis, migration,
cell survival, protein synthesis, axonal growth, and synaptogenesis
(2–5). Neuronal death is a prominent pathologic effect of fetal alcohol
exposure. This loss of neurons may underlie many of the behavioral
deficits observed in fetal alcohol syndrome.The vulnerability of neurons
to alcohol neurotoxicity differs among brain regions and changes with
developmental stages (6, 7). The causes for ethanol-induced neuronal
loss remain incompletely elucidated, as are the cellular and molecular
mechanisms underlying the spatiotemporal window of susceptibility.
The double-stranded RNA (dsRNA)2-activated protein kinase (PKR)
is a serine/threonine protein kinase ubiquitously expressed in mamma-
lian cells (8, 9). PKR is initially identified as an interferon-induced pro-
tein that is activated in virus-infected cells by dsRNA produced during
the virus life cycle (10, 11). PKR consists of two functionally distinct
domains, anN-terminal dsRNAbinding regulatory domain and aC-ter-
minal catalytic domain. PKR is activated by dsRNA (11); interaction
with dsRNA causes PKR to form homodimers and to autophosphoryl-
ate on multiple serine/threonine residues, including threonine 446 and
451 (12–14). PKR is a component of signal transduction pathwaysmedi-
ating many important cellular functions, such as survival, proliferation,
differentiation, and stress responses (10, 12, 15, 16). In addition to
dsRNA, PKR can be activated by cytokines, growth factors, serum dep-
rivation, bacterial products, or physiochemical stress (12, 16, 17).
Recent studies indicate that dsRNA-independent activation may be
mediated by protein activators of PKR, PACT, and its mouse homo-
logue, RAX (18–20). Following autophosphorylation, PKR catalyzes the
phosphorylation of target substrates, the most well characterized being
the-subunit of eukaryotic initiation factor-2 (eIF2) (12). Phosphoryl-
ated eIF2 sequesters eIF2B, a rate-limiting component of translation,
leading to an inhibition of protein synthesis in the cells. In some cases,
eIF2 phosphorylation leads to cell death (21).
In this study,we have demonstrated that ethanol promotes PKR/RAX
interaction; this interaction in turn activates PKR and induces eIF2
phosphorylation. The levels of RAX expression determine the cellular
sensitivity to ethanol. These findings provide important insight into the
mechanisms of ethanol-induced damage to the CNS.
EXPERIMENTAL PROCEDURES
Materials—Sprague-Dawley rats were obtained from Hilltop Labo-
ratory Inc. (Scottdale, PA). 2-Aminopurine (2-AP) was purchased from
Sigma, and a selective PKR inhibitor was purchased from Calbiochem
(La Jolla, CA; catalogue number 527450). All antibodies, except anti-
PACT and anti-ATF4, were obtained from Cell Signaling Technology
(Beverly, MA). The anti-PACT and anti-ATF4 antibodies were pur-
chased from Santa Cruz Biotechnology (Santa Cruz, CA).
Cell Culture and Treatment—Human neuroblastoma cells (SH-SY5Y
and SK-N-MC cells) and a human embryonic kidney cell line (HEK293)
were obtained from the American Type Culture Collection. These cells
were grown in minimum Eagle’s medium containing 10% fetal bovine
serum, 2 mM L-glutamine, and 25 g/ml gentamycin at 37 °C with 5%
CO2. PKR/ and PKR/ mouse embryonic fibroblasts (MEFs)* This research was supported by Grants AA015407 and AA013984 from the National
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Chinese Academyof Sciences (30470544). The costs of publication of this articlewere
defrayed in part by the payment of page charges. This article must therefore be
hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to
indicate this fact.
1 To whom correspondence should be addressed: Dept. of Microbiology, Immunology,
and Cell Biology, West Virginia University School of Medicine, Morgantown, WV
26506. Tel.: 304-293-7208; Fax: 304-293-7823, E-mail: jluo@hsc.wvu.edu.
2 The abbreviations used are: dsRNA, double-stranded RNA; CNS, central nervous sys-
tem; eIF2, eukaryotic initiation factor-2; HA, hemagglutinin; MEF, mouse embry-
onic fibroblasts; PACT, PKR-activating protein; PERK, PKR-like endoplasmic reticular
kinase; PKR, double-strandedRNA-activatedprotein kinase; RAX, PKR activator X;WT,
wild-type; 2-AP, 2-aminopurine; IL, interleukin; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide; p-, phosphorylated.
THE JOURNAL OF BIOLOGICAL CHEMISTRY VOL. 281, NO. 23, pp. 15909–15915, June 9, 2006
© 2006 by The American Society for Biochemistry and Molecular Biology, Inc. Printed in the U.S.A.
JUNE 9, 2006•VOLUME 281•NUMBER 23 JOURNAL OF BIOLOGICAL CHEMISTRY 15909
were obtained from Dr. Antonis E. Koromilas (Lady Davis Institute for
Medical Research,McGill University, Quebec, Canada) andmaintained
in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal
bovine serum and penicillin-streptomycin (100 units/ml) at 37 °C with
5% CO2. Cerebellar granule neurons (CGNs) were isolated from the
cerebella of 7-day-old rat pups. CGNs were cultured for 48 h before
exposing them to ethanol in vitro. The procedure for preparation and
culture of CGNs has been previously described (22, 23).
Ethanol Exposure Protocol—Due to the volatility of ethanol, amethod
utilizing sealed containers was used to maintain ethanol levels in the
culture medium (24). With this method, ethanol concentrations in the
culture medium could be accurately maintained. In vivo ethanol expo-
surewas achieved through intragastric intubation as described byGreen
et al. (25). Briefly, two male and two female pups (postnatal day 9) of a
given litter were given ethanol (6.72 g/kg/day) by two intragastric intu-
bations separated by 2 h. The mean blood alcohol concentration pro-
duced by the paradigm is352 mg/dl. For controls, two male and two
female pups of the same litter received the same intubation procedure
without ethanol exposure (the sham-intubated group). Two paradigms
of ethanol exposure were used. With a short exposure, ethanol was
given on only postnatal day 9. With a paradigm of longer exposure,
ethanol was delivered during postnatal days 6–9. Two hours after the
last intubation, the pups were sacrificed and cerebella were dissected.
Proteins were extracted and stored at 80 °C until further used. All
animal protocols were approved by the Animal Care and Use Commit-
tee of West Virginia University and complied with the National Insti-
tutes of Health guidelines for animal care and use.
MTT Assay—The number of viable cells in culture was determined
by the MTT assay as previously described (22).
Cell Transfection and Establishment of Stable Transfectants—He-
magglutinin (HA)-tagged RAX construct and S18A mutant (substitu-
tion of serine 18 to alanine) carried by vector pcDEF3 were generous
gifts fromDr. StratfordMay (University of Florida, Gainesville, FL) (26).
Cell transfection was carried out with Lipofectamine 2000 reagent
(Invitrogen) according to the manufacturer’s instructions. Stable cell
clones expressing exogenous RAX were screened by the treatment of
G418 (600 g/ml) for 3–4 weeks. Positive clones were verified by the
expression of HA as well as the overexpression of RAX. The clones
expressing the highest level of RAX were selected.
Protein Synthesis Assay—Protein synthesis was measured by the incor-
poration of 14C-labeled amino acids (Amersham Biosciences; catalogue
numberCFB104). Briefly, cells were seeded in 24-well cell culture trays at
the density of 5 105 cells/well. After ethanol treatment for the indi-
cated time, 3 Ci of 14C-labeled amino acid mix was added to the wells
and incubated at 37 °C for 20 min, and then the medium was removed;
the cells were lysed with 1 volume of cold radioimmune precipitation
assay buffer (150 mM NaCl, 50 mM Tris, pH 8, 1% Nonidet P-40, 0.1%
SDS, 0.5% deoxycholic acid sodium, 0.1% mg/ml phenylmethylsulfonyl
fluoride, 1 mM sodium orthovanadate, and 3% aprotinin). Reactions
were stopped by the addition of 1 volume of cold 20% trichloroacetic
acid. The acid-insoluble fractions were collected on Whatman glass
fiber filters (47 mM GF/A), and radioactivity was measured by a liquid
scintillation counter.
Immunohistochemistry—Cerebella were sectioned parasagitally at a
thickness of 12 m using a cryostat and stored at 20 °C until further
processing. The expression of RAX in the cerebella was determined by
immunohistochemistry using a specific anti-PACT antibody (catalogue
number 18768; Santa Cruz Biotechnology). The procedure for immu-
nohistochemistry has been previously described (27). The specificity of
this antibody has been confirmed by immunoblots. Negative controls
were performed by omitting the primary antibody.
Immunoblotting and Immunoprecipitation—The procedure for immu-
noblotting has been previously described (22). Immunoprecipitation
was performed as previously described (28). Briefly, an aliquot of cell
lysate containing 200 g of protein was incubated with either anti-PKR
or anti-PACT antibody (1:50) overnight at 4 °C. Twenty microliters of
protein A/G conjugated to agarose (Santa Cruz Biotechnology) were
added to the lysate, and the mixture was incubated for 3 h at 4 °C.
Immunoprecipitates were collected by centrifugation at 10,000 g for
10 min. The pellet was washed three times with 0.5 ml of radioimmune
precipitation assay buffer. Thereafter, the pellets were resuspended in
20 l of 3 SDS sample buffer and analyzed for the expression of spe-
cific proteins by immunoblotting. The amount of protein expression
was quantified with a densitometer using the software Optimas version
6.2 (Media Cybernetics, Silver Spring, MD).
Statistical Analysis—Differences among treatment groups were tested
using analysis of variance. Differences in which p0.05 were consid-
ered statistically significant. In cases where significant differences were
detected, specific post hoc comparisons between treatment groups
were examined with Student-Newman-Keuls tests.
RESULTS
Ethanol Induces Phosphorylation of PKR and eIF2—The effect of
ethanol on the phosphorylation of PKR and eIF2was first examined in
SH-SY5Y cells. Ethanol (200 and 400 mg/dl) modestly increased phos-
phorylation of PKR and eIF2; at 400 mg/dl, it caused a more sustained
phosphorylation of PKR and eIF2 (Fig. 1A). As a result, the expression
FIGURE 1. Effect of ethanol on PKR and eIF2 phosphorylation in vitro. A, SH-SY5Y
cells cultured in serum-free medium were exposed to ethanol (0, 200, or 400 mg/dl) for
0.5–24h. Cellular proteinwasextractedandanalyzedby immunoblottingusingantibod-
ies directed against either phosphorylated PKR or eIF2 (p-PKR or p-eIF2) as described
under “Experimental Procedures.” The expression of a downstream target of p-eIF2
(ATF4) was also examined. B, expression of PACT/Rax, PKR, eIF2, and p-eIF2 in human
embryonic kidney cell lineHEK293 (293), humanneuroblastomaSK-N-MC (MC ), SH-SY5Y
(5Y ) cells, and cerebellar granule neurons (CGNs) was determined by immunoblotting.
CGNswere isolated from the rat cerebella of 7-day-old rat pups. C, effect of ethanol (0 or
400 mg/dl) on PKR phosphorylation in human embryonic kidney cell line HEK293 (293),
human neuroblastoma SK-N-MC (MC ), SH-SY5Y (5Y ) cells, and cerebellar granule neu-
rons (CGNs) was determined by immunoblotting as described above. The experiment
was replicated three times.
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of a downstream effector of p-eIF2, ATF4, was up-regulated by etha-
nol exposure. We examined the expression of PACT/RAX in neuronal
cells (SH-SY5Y and SK-N-MCneuroblastoma cells and primary CGNs)
and a non-neuronal cell line (embryonic kidney cell line HEK293). Con-
sistent with previous findings showing the expression of PACT/RAX as
generally low in mammalian cells (18, 19, 29), these cells expressed
PACTwith low abundance. Among these cells, CGNs isolated from rats
of postnatal day 7 exhibited the highest expression of RAX (Fig. 1B).
Interestingly, CGNs (the cells with the highest PACT/RAX expression)
were also most sensitive to ethanol-stimulated PKR phosphorylation
(Fig. 1, B and C).
The developing rat cerebellum has been extensively used for investi-
gating ethanol-induced neurotoxicity. Cerebellum of postnatal days
4–10 represents awindowof vulnerability to ethanol exposure (30–32).
We examined the expression of RAX, PKR, and eIF2 in the developing
cerebellum. A rapid increase in RAX expression was observed during
postnatal days 6–9 (Fig. 2A). RAX expression decreased slightly from
postnatal day 12 and remained stable thereafter. The phosphorylated
form of PKR and eIF2 increased dramatically from postnatal day 9 and
continued to remain at a high level.We also examined the expression of
another eIF2 kinase, PKR-like endoplasmic reticular kinase (PERK).
Interestingly, the level of phosphorylated PERK was relatively low dur-
ing postnatal days 9–12. Immunohistochemical analysis demonstrated
a strong RAX staining in the external granule layer and Purkinje cell
layer in the cerebellum of postnatal day 9 (Fig. 2B). Some RAX-positive
cells were scattered in the internal granule layer. To determine whether
in vivo exposure to ethanol altered PKR/eIF2 activity, we delivered
ethanol to rat pups through intragastric intubation. As shown in Fig. 3,
ethanol exposure increased the phosphorylation of PKR and eIF2 in
the cerebella of postnatal day 9 rats (Fig. 3). Ethanol did not affect the
expression of RAX, PKR, and eIF2. Similar results were observed fol-
lowing longer exposure to ethanol (postnatal days 6–9) (data not
shown).
In addition to PKR, other eIF2 kinases can also phosphorylate eIF2;
these include PERK, heme-regulated inhibitor and GCN2 family mem-
bers (16). We therefore sought to determine whether ethanol-induced
eIF2 phosphorylation was mediated by PKR. As shown in Fig. 4A, two
selective inhibitors of PKR (2-AP and PKR-I) effectively blocked etha-
FIGURE 2. Expression of RAX in the developing
cerebellum. A, cerebella were isolated from rat
pups aged from postnatal days (PDs) 3 to 21. The
expression of RAX, PKR, eIF2, and PERK was
determined by immunoblotting. The ratio of
p-eIF2/eIF2 is given at the upper panel on the
right. A positive control for phosphorylated PERK
(SH-SY5Y cells treatedwith thapsigargin) is shown
at the lower panel on the right. The experiment
was replicated three times. B, localization of RAX
was determined by immunohistochemistry. Neg-
ative controlswereperformedbyomitting thepri-
mary antibody. EGL, external granule layer; ML,
molecular layer; PCL, Purkinje cell layer; IGL, inter-
nal granule layer. A representative image of the
cerebellum from a postnatal day 9 rat pup is
shown. Scale bar 150 M.
FIGURE3.Effectofethanolon thedevelopingcerebellum.Four ratpups (9-day-old) of
a given litter were exposed to ethanol (EtoH ) through intragastric intubation as
described under “Experimental Procedures.” As a control, four rat pups received the
same intubation procedurewithout ethanol exposure (the Sham-intubated group). Two
hours after the second intubation (4 h following initial ethanol exposure), the pupswere
sacrificed and cerebella were dissected. The expression of RAX and phosphorylated as
well as total PKR and eIF2was determined by immunoblotting. Each lane represents a
sample collected from an individual pup. The experiment was replicated three times.
Ethanol Affects PKR and RAX
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nol-induced eIF2 phosphorylation in SH-SY5Y cells, suggesting that
PKR was involved in ethanol-induced eIF2 phosphorylation. The
observation was further validated by an experiment using PKR knock-
out MEFs. As shown in Fig. 4B, ethanol promoted eIF2 phosphoryla-
tion in PKR/ cells, but not in PKR/ MEF cells. Consistently,
ethanol increased ATF4 expression only in PKR/ cells (Fig. 4B).
Overexpression of PACT/RAX Enhances Sensitivity to Ethanol—The
correlation between PACT/RAX expression and ethanol-induced PKR/
eIF2 phosphorylation led us to postulate that PACT/RAXplayed a role
in the action of ethanol. To determine whether a high expression of
PACT/RAX facilitated ethanol-induced PKR/eIF2 phosphorylation,
we artificially increased the levels of PACT/RAX expression by trans-
fecting SK-N-MC cells with either a wild-type (WT) or amutant (S18A)
RAX cDNA. It has been previously shown that phosphorylation of RAX
at serine 18 plays an essential role in PKR activation. Overexpression of
RAX was verified by immunoblotting using anti-HA and anti-PACT
antibodies (Fig. 5A). As shown in Fig. 5B, overexpression ofWTRAX in
SK-N-MC cells dramatically enhanced ethanol-stimulated PKR and
eIF2 phosphorylation, compared with vector-transfected cells. In con-
trast, overexpression of S18A RAX inhibited ethanol-induced PKR/
eIF2 phosphorylation. We then established stable transfectants over-
expressing WT or S18A RAX and examined the effect of ethanol on
PKR and eIF2 phosphorylation; similar results were obtained (Fig. 5C).
The observation was not limited to neuronal cells; overexpression of
RAX also sensitizedHEK293 cells to ethanol-induced PKR/eIF2 phos-
phorylation (Fig. 5D). These findings validated that a high expression of
PACT/RAX facilitated ethanol-mediated PKR/eIF2 phosphorylation.
Ethanol Promotes the Interaction between PKR and PACT/RAX—We
sought to determine whether ethanol promoted the interaction
between PKR and PACT/RAX. We examined the effect of ethanol on
the association between PKR and PACT/RAX in SK-N-MC cells stably
transfected withWTRAX, S18A RAX, or an empty vector. As shown in
Fig. 6, the association between RAX and PKRwas demonstrated by their
co-immunoprecipitation. In cells overexpressing WT RAX, ethanol
promoted the association between PKR and PACT/RAX. Although
PKR and S18A RAX were co-immunoprecipitated, ethanol failed to
enhance the association between PKR and PACT/RAX in cells overex-
pressing S18A RAX (Fig. 6, bottom panel). No co-immunoprecipitation
of PKR and PACT/RAXwas detected in the cells expressing vector only.
This was probably because of the low endogenous level of PACT/RAX
in SK-N-MC cells. We also observed that ethanol enhanced PKR and
PACT/RAX association inHEK293 cells overexpressingWTRAX (data
not shown). In all cases, however, ethanol did not promote PKR binding
to RAX in cells overexpressing S18A RAX.
Overexpression of PACT/RAX Enhances Ethanol-induced Protein
Synthesis Inhibition and Cell Death—The activity of eIF2 regulates
protein synthesis. Since we showed that eIF2 phosphorylation was
enhanced by ethanol in a PACT/RAX-dependentmanner, we sought to
determine whether ethanol-inhibited protein synthesis also depended
on the status of PACT/RAX expression. As shown in Fig. 7, ethanol
exposure (400mg/dl, 6 h) decreased the rate of protein synthesis by 32%
in vector-transfected SK-N-MC cells; however, it inhibited the rate of
protein synthesis by 63% in cells overexpressingWTRAX. Ethanol only
modestly (16%) affected protein synthesis in cells transfected with S18A
RAX. A similar result was observed following exposure to ethanol for
12 h (Fig. 7). During this period of exposure (6–12 h), ethanol did not
significantly affect cell number (data not shown). Therefore, the
decrease in the rate of protein synthesis did not result from an alteration
in cell number.
We further determined whether PACT/RAX modulated the effect of
ethanol on cell survival. As shown in Fig. 8, ethanol (400 mg/dl, 48 h)
decreased the number of SK-N-MC cells transfectedwith an empty vector
by16%.Ontheotherhand, inSK-N-MCcells stably transfectedwithWT
RAX, ethanol-induced cell losswas increased to 33%. Ethanol failed to alter
FIGURE 4. PKRmediates ethanol-induced phos-
phorylation of eIF2. A, SH-SY5Y cells were pre-
treated with PKR inhibitors, 2-AP (10mM), or PKR-I
(500nM) for 30minand thenexposed toethanol (0
or 400mg/dl) for 2–6 h. The expression of p-eIF2
was determined by immunoblotting. B, PKR/
and PKR/MEFs were exposed to ethanol (0 or
400 mg/dl) for 2–6 h. The expression of p-eIF2
was determined by immunoblotting. The expres-
sion of a downstream target of p-eIF2 (ATF4) was
also examined. The ratio of p-eIF2/eIF2 is
shown at the panel on the right. The experiment
was replicated three times.
Ethanol Affects PKR and RAX
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the number of cells overexpressing S18A RAX. Because these cells were
maintained in serum-free medium and did not proliferate, the decrease in
cell number must have resulted from ethanol-induced cell death. Further-
more, pretreatment of 2-AP was sufficient to block ethanol-induced cell
loss (Fig. 8). The protective effect of PKR inhibition was observed using
another selective PKR inhibitor (data not shown). This indicated that the
effect of ethanol was mediated by PKR.
FIGURE 5. Effect of ethanol on the phosphorylation of PKR and eIF2 in SK-N-MC
cells overexpressing wild-type (WT) and mutant (S18A) RAX. A, SK-N-MC cells were
transiently transfected with either an empty vector or a vector carrying a wild-type RAX
(WT) or amutant (S18A) RAX cDNA that was taggedwith a HA sequence. The expression
of exogenous RAX was determined by immunoblotting using an anti-HA antibody, and
overexpression of RAXwas verified by immunoblotting using an anti-PACT antibody. Ct,
control. B, forty-eight hours after the transfection with RAX (WT or S18A), SK-N-MC cells
were exposed to ethanol (0 or 400 mg/dl) for 2–6 h. The phosphorylation of PKR and
eIF2was determined as described above. C, SK-N-MC cells that stably expressedWT or
S18A RAX were established as described under “Experimental Procedures.” These cells
were exposed to ethanol (0 or 400 mg/dl) for 2–6 h. The phosphorylation of PKR and
eIF2was determined as described above. D, HEK293 cells were transiently transfected
with eitherWT or S18A RAX and then exposed to ethanol (0 or 400mg/dl) for 2–6 h. The
phosphorylation of PKR and eIF2was determined as described above. The experiment
was replicated three times.
FIGURE6.EthanolpromotesanassociationbetweenRAXandPKR.SK-N-MCcells that
stably overexpressed either WT or S18A RAX were exposed to ethanol (0 or 400 mg/dl)
for 2–6 h, and cell lysates were collected. Top panel, two hundred g of cell lysates for
each treatment group were immunoprecipitated (IP) with an anti-PKR antibody and
probedwith either an anti-RAX or PKR antibody.Middle panel, cell lysates for each treat-
ment group were immunoprecipitated with an anti-PACT antibody and probed with
antibodies directed against p-PKR, PKR, or PACT. Bottompanel, cell lysates for each treat-
ment group were immunoprecipitated with an anti-HA antibody and probed with anti-
bodies directed against p-PKR, PKR, or HA. The experiment was replicated three times.
IB, immunoblot.
FIGURE 7. Effect of ethanol on protein synthesis. SK-N-MC cells that stably overex-
pressed eitherWTor S18ARAXwere exposed to ethanol (0 or 400mg/dl) for 6–12 h. The
rate of protein synthesiswasdeterminedasdescribedunder “Experimental Procedures.”
The cells stably transfectedwith an empty vectorwere used as a control. The experiment
was replicated three times. The asterisk denotes significant difference from controls
(transfected with an empty vector).
Ethanol Affects PKR and RAX
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DISCUSSION
Ethanol-mediated PKR/RAX Interaction—PKR is a ubiquitously
expressed serine/threonine kinase. Traditionally, PKR has been studied
in the context of the host anti-viral response (15, 16). PKR contains two
dsRNA binding domains and is activated by viral dsRNA, resulting in
the phosphorylation of a physiological substrate of PKR, eIF2, and
consequent translation inhibition. In addition to its role in translation,
PKR has been implicated as a signal integrator in transcriptional control
pathways (16). For example, the activity of transcription factors, such as
NFB, p53, STAT1, and STAT3, is regulated by PKR (16). PKR is also an
essential mediator of signaling by both cytokines and growth factors
(16). PKR participates in the signaling of the stress-activated protein
kinase (p38) and c-Jun NH2-terminal kinase (JNK) in response to extra-
cellular signals acting through cell surface receptors (16). PKR can be
activated under many circumstances that lack apparent sources of
dsRNA. This dsRNA-independent activation is believed to be mediated
by the PKR-activating protein PACT and its mouse homologue RAX
(18, 19, 26). PACT and RAX are the only known cellular activators for
PKR so far; they are 98% identical in amino acid sequence and contain
three conserved dsRNA binding motifs. It has been demonstrated that
PACT/RAX can efficiently activate PKR in vitro, a cell-free system (18,
19). However, in vivo, PACT/RAX-mediated activation is dependent on
stress applications to the cells (18, 20, 26, 33). Our study indicates that
PACT/RAX is an importantmediator of the action of ethanol. Although
ethanol only induces a modest activation of PKR/eIF2 in cells express-
ing low PACT/RAX, a high expression of PACT/RAX dramatically
enhances ethanol-induced PKR/eIF2 phosphorylation. Ethanol appar-
ently does not affect the expression of PACT/RAX; it promotes the
association between PACT/RAXand PKR. Ethanol enhances co-immu-
noprecipitation of RAX and PKR in cells overexpressing PACT/RAX. In
control cells, however, we do not observe this enhancement. This is
probably because of the low abundance of PACT/RAX in these cells.
Similar to ours, several studies show that other stress signals caused by
serum starvation, arsenite, thapsigargin, peroxide, and IL-3 deprivation
can promote PACT/RAX and PKR association, which leads to PKR
activation and eIF2 phosphorylation (18, 20, 26).
Phosphorylation of RAX at serine 18 seems critical for its effect on
PKR activation. Bennett et al. (26) demonstrate that IL-3 deprivation
enhances RAX/PKR association and RAX phosphorylation at serine 18
in hematopoietic cells. Overexpression of the non-phosphorylatable
mutant of RAX, S18ARAX, inhibits IL-3 deprivation-induced PKR acti-
vation. Furthermore, their results suggest that RAX/PKR association
precedes both RAX phosphorylation and PKR activation. Based on
these findings, Bennett et al. (26) propose a model RAX/PKR interac-
tion. In this model, PACT/RAX first associates with PKR and is then
phosphorylated at serine 18; phosphorylation of PACT/RAX at serine
18 may induce a conformational change in PACT/RAX that allows its
C-terminal dsRNA binding domain to interact and activate PKR. The
S18A RAX, although still able to associate with PKR, fails to activate
PKR following stress. Our study using neuronal cells supports the con-
clusion that phosphorylation of RAX in serine 18 is critical for PKR
activation in response to ethanol; overexpression of S18A RAX inhibits
ethanol-induced PKR/eIF2 phosphorylation. S18ARAX functions as a
“dominant negative protein” and blocks ethanol-mediated alteration.
S18A RAX and PKR are co-immunoprecipitated in the absence of eth-
anol, indicating that RAX lacking phosphorylation at serine 18 is still
able to bind PKR (Fig. 6). However, our results reveal that ethanol can-
not effectively promote the association between S18A RAX and PKR.
Therefore, phosphorylation at serine 18 is important for RAX/PKR
association in response to ethanol exposure.
Ethanol stimulates eIF2 phosphorylation in a PACT/RAX-depend-
ent manner. In addition to PKR, other eIF2 kinases also phosphorylate
eIF2. These include PERK, heme-regulated inhibitor, and GCN2 fam-
ilymembers (16). Using selective PKR inhibitors, we have demonstrated
that PKR mediates ethanol-induced eIF2 phosphorylation. The argu-
ment is further validated by the study using PKR/ MEFs; ethanol
fails to stimulate eIF2 phosphorylation in PKR/MEFs.
Protein Synthesis and Cell Survival—It has been shown that ethanol
inhibits protein synthesis (34, 35). However, the underlying mecha-
nisms remain incompletely elucidated. Lang et al. (36) demonstrate that
ethanol feeding decreases hepatic eIF2B activity and increases eIF2
phosphorylation in vivo. In the reticulocyte cell-free system, ethanol
inhibits peptide chain initiation through increased phosphorylation of
eIF2 (37, 38). Our results support the conclusion that eIF2 is in-
volved; we have identified that PKR, an eIF2 kinase, is a target of eth-
anol.We have further revealed that the status of PACT/RAX expression
in a given cell determines sensitivity to ethanol-induced translational
inhibition. The importance of PACT/RAX status for translational reg-
ulation has been demonstrated in response to other stress signals. For
example, overexpression of PACT/RAX is shown to potentiate transla-
tional inhibition caused by ceramide exposure or IL-3 deprivation (26,
33). Our study provides an insight into the mechanisms of ethanol-
induced translational inhibition.
Ethanol exposure induces the death of certain types of cells under
some circumstances (5, 23, 39, 40). Our results indicate that the PKR/
eIF2 pathway plays a role in ethanol-mediated cell death. Both PKR
and eIF2 have been reported to have involvement in apoptotic mech-
anisms (15, 17). Our study shows that the status of PACT/RAX expres-
sion is important in determining susceptibility to ethanol. Overexpres-
sion of WT RAX potentiates ethanol-mediated PKR activation and
subsequent cell death. In contrast, S18A RAX has a dominant negative
effect and alleviates ethanol-induced cell death. Thus, phosphorylation
of RAX at serine 18 is necessary for PKR activation and subsequent cell
death caused by ethanol exposure. Overexpression of PACT in NIH-
3T3 and HeLa cells induces apoptosis and also potentiates cell death
induced by other stress signals caused by serum-starvation, arsenite,
and peroxide (20). However, our study using neuronal cells as well as
other reports using leukemia cells indicate that overexpression of RAX
is not sufficient to cause cell death (18, 26). Instead, high expression of
RAX enhances cell death caused by ethanol, ceramide, and IL-3 depri-
FIGURE 8. Effect of ethanol on cell survival. SK-N-MC cells that stably overexpressed
eitherWTor S18ARAXwerepretreatedwith aPKR inhibitor, 2-AP (10mM), for 30min and
then exposed to ethanol (Et) (0 or 400 mg/dl) for 48 h. The number of viable cells was
determined by MTT assay as described under “Experimental Procedures.” The experi-
ment was replicated three times. The asterisk denotes significant difference from con-
trols (transfectedwith an empty vector) (Ct). # denotes significant difference fromempty
vector-transfected and ethanol-exposed cells.
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vation. Therefore, whether or not high expression of PACT/RAX
induces cell death is cell type-dependent.
Activation of PKR causes cell death through either transcriptional or
translational mechanisms (15). A number of cell signaling mechanisms
involving FADD, NFB, p38, and JNK have been implicated in PKR-
regulated cell death (15, 16). On the other hand, inhibition of translation
may induce apoptosis or enhance the cell death caused by different
stimuli (21, 41). Although phosphorylation of eIF2 causes a general
block in protein synthesis, translation of mRNAs encoding pro-apo-
ptotic functions, such as GADD153, has been suggested under these
conditions (15, 42). It remains to be determined which downstream
signaling components of PKR/eIF2 are responsible for ethanol-in-
duced cell death.
Implication in Ethanol-induced Damage to the Developing CNS—It
appears that the extent of ethanol-induced PKR/eIF2 phosphorylation
correlates to the expression level of PACT/RAX in a given cell (Fig. 1).
Overexpression of PACT/RAX potentiates the effect of ethanol on
PKR/eIF2 phosphorylation as well as protein synthesis and cell sur-
vival. PACT and RAX are generally less abundant and ubiquitously
expressed; unlike PKR, PACT and RAX are not regulated by interferons
or dsRNA (18, 19, 29).
The cerebellum is one of the CNS regions most susceptible to etha-
nol; rodent cerebellum of an early postnatal period, which is equivalent
to the third trimester in humans, is extensively used for modeling eth-
anol-induced CNS damage (43). Developmental ethanol exposure
causes a significant reduction in volume,weight, and protein contents of
the cerebellum (32, 44–47). In particular, ethanol exposure during
postnatal days 4–10 results in a significant loss of two major neuronal
populations of the cerebellum, Purkinje cells and granule neurons (6, 32,
48).We have demonstrated here that RAX is developmentally regulated
in the cerebellum; a rapid increase is observed during postnatal days
6–9, which falls in the temporal window of ethanol vulnerability. A
strong expression of RAX is localized in the Purkinje cell layer and
external granule layer. Ethanol exposure during this susceptiblewindow
activates the PKR/eIF2 pathway in the cerebellum, suggesting that the
PACT/RAX/PKR/eIF2 pathwaymaymodulate the effect of ethanol on
the CNS. To fully evaluate the role of the PACT/RAX/PKR/eIF2 sys-
tem in ethanol neurotoxicity, a systematical study of the spatiotemporal
expression of PACT/RAX in the CNS is necessary.
PKR has recently emerged as a potential mediator of neurodegenera-
tion (49). For example, -amyloid (A) peptide activates PKR/eIF2
and induces the death of neurons in culture (50, 51). Activated PKR has
been shown to associate with A plaques (49). PKR is suggested to be
involved in the extrastriatal degeneration in Parkinson disease andHun-
tington disease; accumulation of phosphorylated PKR is observed in the
nucleus of neurons affected by these diseases (52). PKR preferentially
binds tomutant huntingtin RNA transcripts, and activated PKR is found
in the brain of Huntington disease (53). Therefore, alteration in the
PACT/RAX/PKR system may not only underlie ethanol neurotoxicity
but also be involved in the CNS damages caused by other insults.
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